Why the study?
Does weekly vinblastine therapy induce long-term remission in patients with advanced Kaposi's sarcoma?
Does weekly vinblastine therapy induce long-term remission in patients with advanced Kaposi's sarcoma?
Weekly vinblastine therapy can induce long-term complete or partial remissions in patients with advanced Kaposi's sarcoma without significant toxicity.
Answers are grounded in this paper and cite their sources.
May support durable remissions with vinblastine in advanced Kaposi sarcoma; hypothesis-generating and requires prospective trials before practice change.
Four patients with advanced Kaposi's sarcoma who were treated with weekly vinblastine therapy achieved long-term remissions. Three patients are still in complete remission at two years, four years, and four years respectively, while the fourth achieved excellent partial remission lasting seven-and-one-half years. The regimen produced no toxicity. We suggest the use of vinblastine as a useful chemotherapeutic agent for Kaposi's sarcoma.
No takes yet. Share an insight, caveat, or question.
Greenwald et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: